1-3 of 3
Chisato Mizutani, MD
Close
Sort by
Journal Articles

Risk Factors and Prognosis of Hemorrhagic Cystitis after Allogeneic Stem Cell Transplantation: Retrospective Analysis in a Single Institution

Yasuyuki Arai, MD, Takeshi Maeda, MD, Hiroyuki Sugiura, MD, Hiroyuki Matsui, MD, Tomoko Moriwake, MD, Tomoyasu Jo, MD, Tomoaki Ueda, MD, Kazuya Okada, MD, Takahito Kawata, MD, Tatsuhito Oonishi, MD, Chisato Mizutani, MD, Fumio Matsuyama, MD, Yasunori Ueda, MD
Journal: Blood
Blood (2010) 116 (21): 2304.
https://doi.org/10.1182/blood.V116.21.2304.2304
Published: 2010
Journal Articles

Risk of Hepatitis B Virus (HBV) Reactivation and Efficacy of Antiviral Preemptive Therapy in Malignant Lymphoma Patients Who Have Resolved HBV.

Takeshi Maeda, MD, Tomoaki Ueda, MD, Tomoyasu Jo, MD, Kazuya Okada, MD, Yasuyuki Arai, MD, Takahito Kawata, MD, Takeshi Ito, MD, Satoko Morita, MD, Tatsuhito Onishi, MD, Chisato Mizutani, MD, Fumio Matsuyama, MD, Yasunori Ueda, MD
Journal: Blood
Blood (2009) 114 (22): 2918.
https://doi.org/10.1182/blood.V114.22.2918.2918
Published: 2009
Journal Articles

Reduced Intensity Conditioning (RIC) with Cladribine, Busulfan and 4 Gy Total Body Irradiation (TBI) for Bone Marrow Transplantation (BMT) from an HLA-Matched Unrelated Donor (URD): A Prospective Multi-Institutional Clinical Trial.

Sung-Won Kim, MD, Masayuki Hino, MD, Kazuo Hatanaka, MD, Yasunori Ueda, MD, Ryuji Tanosaki, MD, Makoto Hirokawa, MD, Shin-ichiro Mori, MD, Kazunori Nakase, MD, Toshiro Ito, MD, Chihiro Shimazaki, MD, Yasukazu Kawai, MD, Kazutaka Sunami, MD, Hirohisa Nakamae, MD, Toshiharu Tamaki, MD, Chisato Mizutani, MD, Masahiro Kami, MD, Takahiro Fukuda, MD, Kinuko Tajima, Koji Nagafuji, MD, Shuichi Taniguchi, MD, Yoichi Takaue, MD, Mine Harada, MD
Journal: Blood
Blood (2006) 108 (11): 5397.
https://doi.org/10.1182/blood.V108.11.5397.5397
Published: 2006